Enzon Pharmaceuticals Inc. v Nektar Therapeutics

Motion No: M-6046

Slip Opinion No: 2017 NYSlipOp 63292(U)

Decided on February 2, 2017

Appellate Division, First Department, Motion Decision

Published by New York State Law Reporting Bureau pursuant to Judiciary Law § 431.

This motion is uncorrected and is not subject to publication in the Official Reports.

February 2, 2017

Enzon Pharmaceuticals, Inc.,

(formerly known as Enzon, Inc.),

Plaintiff-Appellant,

v

Nektar Therapeutics (formerly known

as Inhale Therapeutic Systems, Inc.),

Defendant-Respondent.

Defendant-respondent having moved for clarification/ reargument of, or in the alternative, for leave to appeal to

the Court of Appeals, from the decision and order of this Court, entered on October 25, 2016 (Appeal No. 2040), Now, upon reading and filing the papers with respect to the motion, and due deliberation having been had thereon, It is ordered that the motion is denied. ENTERED: February 2, 2017 _____________________ CLERK

PRESENT: Hon. Rolando T. Acosta,Justice Presiding, Dianne T. Renwick David B. Saxe Paul G. Feinman Marcy L. Kahn,Justices

M-6046

Index No. 652283/15